PD-1 Monoclonal Antibody trials for Colorectal cancer

All PD-1 Monoclonal Antibody trials · All Colorectal cancer trials

Phase breakdown

Recruiting trials studying PD-1 Monoclonal Antibody for Colorectal cancer

• A Study of SI-B003, BL-B01D1+SI-B003 and BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Esophageal Cancer, Gastric Cancer, Colorectal Cancer and Other Gastrointestinal Tumors
  NCT06008054 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• SBRT + PD-1 Monoclonal Antibody in Unresectable Colorectal Liver Metastases
  NCT06794086 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• SCRT + Chemo Targeted Immuno-neoadjuvant Therapy for High-risk pMMR/MSS RC
  NCT07549399 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study PD-1 Monoclonal Antibody for Colorectal cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.